EP0178299A4 - Sustained release oral dosage form for naproxyn. - Google Patents

Sustained release oral dosage form for naproxyn.

Info

Publication number
EP0178299A4
EP0178299A4 EP19840901535 EP84901535A EP0178299A4 EP 0178299 A4 EP0178299 A4 EP 0178299A4 EP 19840901535 EP19840901535 EP 19840901535 EP 84901535 A EP84901535 A EP 84901535A EP 0178299 A4 EP0178299 A4 EP 0178299A4
Authority
EP
European Patent Office
Prior art keywords
naproxyn
dosage form
sustained release
oral dosage
release oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19840901535
Other languages
German (de)
French (fr)
Other versions
EP0178299A1 (en
Inventor
Charles H Hsiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Key Pharmaceuticals Inc
Original Assignee
Key Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Key Pharmaceuticals Inc filed Critical Key Pharmaceuticals Inc
Publication of EP0178299A1 publication Critical patent/EP0178299A1/en
Publication of EP0178299A4 publication Critical patent/EP0178299A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
EP19840901535 1984-03-21 1984-03-21 Sustained release oral dosage form for naproxyn. Pending EP0178299A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/000431 WO1985004099A1 (en) 1984-03-21 1984-03-21 Sustained release oral dosage form for naproxyn

Publications (2)

Publication Number Publication Date
EP0178299A1 EP0178299A1 (en) 1986-04-23
EP0178299A4 true EP0178299A4 (en) 1987-04-28

Family

ID=22182090

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19840901535 Pending EP0178299A4 (en) 1984-03-21 1984-03-21 Sustained release oral dosage form for naproxyn.

Country Status (2)

Country Link
EP (1) EP0178299A4 (en)
WO (1) WO1985004099A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
IT1256651B (en) * 1992-12-11 1995-12-12 Giancarlo Santus PHARMACEUTICAL COMPOSITION WITH CONTROLLED RELEASE IN LIQUID SUSPENSION
FR2677886B1 (en) * 1991-06-18 1995-03-31 Adir MATRIX TABLET FOR THE EXTENDED RELEASE OF INDAPAMIDE AFTER ORAL ADMINISTRATION.
DE4140185C2 (en) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Medicament containing a 2-arylpropionic acid derivative in nanosol form and its preparation
CN1675154A (en) * 2002-06-07 2005-09-28 科蒂科股份有限公司 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
CN116270902B (en) * 2023-04-26 2024-08-20 南京同仁堂药业有限责任公司 Jingshu granule and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50129727A (en) * 1974-04-04 1975-10-14
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No relevant documents have been disclosed. *
See also references of WO8504099A1 *

Also Published As

Publication number Publication date
EP0178299A1 (en) 1986-04-23
WO1985004099A1 (en) 1985-09-26

Similar Documents

Publication Publication Date Title
GB2210266B (en) Dosage form
PH25701A (en) Pharmaeutial prpearation for oral use
EP0211615A3 (en) Photopolymerisable composition
ZA856387B (en) Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
PH20978A (en) Oral preparation
PH24205A (en) Sustained release dosage forms
EP0371542A3 (en) Oral composition
ZA884603B (en) 2,5-dihydropyrroles
ZA889710B (en) 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
EP0178299A4 (en) Sustained release oral dosage form for naproxyn.
GB8728389D0 (en) Photopolymerisable composition
EP0228457A4 (en) Emergence-promoting rhizobacteria.
EG17521A (en) Etoposide oral dosage form
GB8718528D0 (en) Photopolymerisable composition
GB8718525D0 (en) Photopolymerisable composition
EP0300036A4 (en) Vasopressin-based pharmaceutical compositions.
GR3000539T3 (en) 3,4-dihydro-2h-pyrans
JPS6450861A (en) 3,5-dialkyl-1-arylpyrazoles
GB8630358D0 (en) Photopolymerisable materials
CS569987A1 (en) Zpusob vyroby 2 naftylamin 6,8 disulfonove kyseliny
CS420087A1 (en) Sposob renovacie mechanicky neposkodenych tlacovych platni, znehodnotenych pri vyrobe hlinikovych ofsetovych platni
CS748585A1 (en) Potahovane tablety s obsahem 2,5 mg nebo 5,0 mg trinitratu glycerolu a jeho rizenym ovolnovanim
DE3882331D1 (en) Dose.
GB8700860D0 (en) Photopolymerisable composition
ZA888675B (en) 1,4-disubstituted-piperidinyl compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB LI LU NL SE

17P Request for examination filed

Effective date: 19860308

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KEY PHARMACEUTICALS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 19870428

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KEY PHARMACEUTICALS, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HSIAO, CHARLES, H.